MSFT 453.9631 -2.6353% AAPL 228.225 -2.0409% NVDA 131.2 -2.75% GOOGL 187.56 -1.8935% GOOG 189.16 -1.8167% AMZN 196.37 -1.7118% META 522.38 -2.3023% AVGO 1714.64 -1.7224% TSLA 265.3951 0.811% TSM 187.5 -1.8582% LLY 937.8 -0.2107% V 261.56 -0.5475% JPM 207.67 -0.0626% UNH 505.78 0.9682% NVO 141.2 -1.0789% WMT 69.41 -1.4203% LVMUY 154.5 1.9667% XOM 112.96 0.9292% LVMHF 770.5 1.6491% MA 432.89 -0.173%

Diversified Healthcare Trust

Real Estate US DHC


Last update at 2024-07-11T14:59:00Z

Day Range


52 Week Range



  • Previous Close 3.15
  • Market Cap579.35M
  • Volume263382
  • P/E Ratio-
  • Dividend Yield1.74%
  • EBITDA200.80M
  • Revenue TTM1435.05M
  • Revenue Per Share TTM6.00
  • Gross Profit TTM 171.89M
  • Diluted EPS TTM-1.44


Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -21.11900M 181.36M -133.05700M -82.84200M 292.37M
Minority interest 0.00000M 5.41M 123.39M 140.53M 156.76M
Net income -21.82900M 174.51M -134.30700M -83.27800M 286.87M
Selling general administrative 26.43M 34.09M 30.59M 37.03M 85.89M
Selling and marketing expenses - - - - -
Gross profit 174.50M 291.40M 395.67M 551.09M 665.58M
Reconciled depreciation 239.53M 271.13M 262.74M 282.23M 280.45M
Ebit -75.29000M 6.82M 113.15M 225.97M 294.13M
Ebitda 163.99M 277.95M 383.30M 515.00M 580.37M
Depreciation and amortization 239.28M 271.13M 270.15M 289.02M 286.24M
Non operating income net other 313.80M 468.26M 58.39M -0.90500M 242.35M
Operating income -75.29000M 6.82M 113.15M 225.97M 293.46M
Other operating expenses 1374.79M 1397.03M 1537.10M 815.12M 823.70M
Interest expense 209.38M 255.76M 201.48M 180.11M 179.29M
Tax provision 0.71M 1.43M 1.25M 0.44M 0.48M
Interest income 15.93M 20.64M 18.22M 0.94M 0.67M
Net interest income -193.45400M -235.12400M -183.26200M -179.17100M -178.62000M
Extraordinary items - - - - -
Non recurring 2.60M 17.33M 107.79M 128.30M -66.54000M
Other items - - - - -
Income tax expense 0.71M 1.43M 1.25M 0.44M 0.48M
Total revenue 1283.57M 1383.21M 1632.03M 1040.15M 1117.16M
Total operating expenses 265.71M 305.22M 300.74M 326.05M 372.12M
Cost of revenue 1109.07M 1091.81M 1236.36M 489.07M 451.58M
Total other income expense net 54.17M 174.54M -246.20700M -308.81500M 177.53M
Discontinued operations - - - - -
Net income from continuing ops -21.82900M 174.51M -139.45300M -88.63400M 286.36M
Net income applicable to common shares -15.77400M 174.51M -139.45300M -88.23400M 286.87M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 5446.14M 6002.09M 6623.51M 6476.42M 6653.83M
Intangible assets 33.95M 45.35M 48.75M 286.51M 337.88M
Earning assets - - - - -
Other current assets -328.34800M 30.62M 166.97M 128.87M 224.44M
Total liab 3109.24M 3363.48M 3961.12M 3857.20M 3776.78M
Total stockholder equity 2336.89M 2638.61M 2662.39M 2619.22M 2877.05M
Deferred long term liab - 42.96M 51.66M 32.03M 30.32M
Other current liab 28.13M 29.42M 29.84M 27.30M 30.82M
Common stock 2.40M 2.40M 2.39M 2.38M 2.38M
Capital stock 2.40M 2.40M 2.39M 2.38M 2.38M
Retained earnings -2283.98400M -1980.81700M -1955.47500M -2120.45000M -1878.37100M
Other liab - 259.30M 254.75M 331.09M 244.30M
Good will - - - - -
Other assets 5166.25M 5143.20M 5724.79M 6.12M 159.51M
Cash 246.96M 658.07M 634.85M 74.42M 37.36M
Cash and equivalents - - - - -
Total current liabilities 29.94M 729.42M 829.85M 27.30M 568.32M
Current deferred revenue - - - - -
Net debt 2593.64M 2389.81M 3044.23M 3492.22M 3541.01M
Short term debt 1.81M 700.00M 800.00M 0.69M 537.50M
Short long term debt - 700.00M 800.00M - 537.50M
Short long term debt total 2840.60M 3047.88M 3679.08M 3566.64M 3578.37M
Other stockholder equity 4618.47M 4617.03M 4615.48M 4737.29M 4753.04M
Property plant equipment - 4864.58M 5075.75M 5828.27M 6100.35M
Total current assets 262.49M 688.69M 1016.95M 203.29M 261.79M
Long term investments 129.92M 155.48M 246.67M 73.77M 1.57M
Net tangible assets - 2593.26M 2613.64M 2209.32M 2398.64M
Short term investments - 5.88M 215.13M - -
Net receivables 81.39M 8.72M 82.13M 104.80M 1.99M
Long term debt 2816.85M 2317.70M 2806.81M 3498.81M 2964.16M
Inventory - -8.71600M - - -
Accounts payable - 34.62M 38.12M 48.32M 32.84M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 123.39M 140.53M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2283.98400M - - - -
Additional paid in capital - - - - -
Common stock total equity - 2.40M 2.39M 2.38M 2.38M
Preferred stock total equity - - - - -
Retained earnings total equity - -1980.81700M -1955.47500M -2120.45000M -1878.37100M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5276.55M 5112.58M 5342.70M 5912.85M 6052.59M
Deferred long term asset charges - - - - -
Non current assets total 5183.65M 5313.41M 5606.57M 6273.14M 6392.03M
Capital lease obligations - 30.18M 72.27M 759.40M 76.70M
Long term debt total - 2317.70M 2806.81M 3498.81M 2964.16M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 671.81M 367.04M -2.23900M 104.98M 99.09M
Change to liabilities -1.43500M 6.79M 20.69M -52.67900M 6.68M
Total cashflows from investing activities 387.71M 242.70M -40.43600M 86.17M 99.09M
Net borrowings -666.25900M 778.99M -14.19500M -148.26200M -77.00200M
Total cash from financing activities -675.99800M 746.72M -79.48300M -369.86300M -469.18100M
Change to operating activities 1.64M -65.11600M -13.17500M -50.88500M 3.10M
Net income -15.77400M 179.93M -134.30700M -82.87800M 292.41M
Change in cash -328.64300M 926.10M 38.62M -17.84700M 22.75M
Begin period cash flow 1016.95M 90.85M 52.22M 70.07M 47.32M
End period cash flow 688.30M 1016.95M 90.85M 52.22M 70.07M
Total cash from operating activities -40.35300M -63.32300M 158.54M 265.85M 392.84M
Issuance of capital stock - - - - -
Depreciation 239.53M 263.92M 262.74M 282.23M 280.45M
Other cashflows from investing activities 15.29M 103.26M 147.39M 254.24M 332.39M
Dividends paid 9.57M 9.54M 42.83M 199.72M 370.75M
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock -0.17100M -0.38300M -0.17100M -0.29900M -0.41100M
Other cashflows from financing activities -27.19200M -32.69500M -28.04600M -22.00000M -25.46800M
Change to netincome -330.10200M -500.10300M 92.21M 69.44M -189.33900M
Capital expenditures 299.39M 227.60M 185.59M 18.81M 99.09M
Change receivables - - - - -
Cash flows other operating 59.02M -34.47100M -98.22300M 36.90M -9.37300M
Exchange rate changes - - - - -
Cash and cash equivalents changes -328.64300M 926.10M 38.62M -17.84700M 22.75M
Change in working capital 1.64M -65.11600M -13.17500M -50.88500M 3.10M
Stock based compensation - - - - -
Other non cash items -265.74100M -442.05300M 43.28M 117.37M -183.11800M
Free cash flow -40.35300M -63.32300M 158.54M 265.85M 491.93M

Peer Comparison

Sector: Real Estate Industry: REIT - Healthcare Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Diversified Healthcare Trust
0.17 5.56% 3.33 - - 0.43 0.26 2.25 15.65
Welltower Inc
-0.3 0.29% 104.25 170.68 72.46 7.75 2.13 9.77 27.67
Ventas Inc
0.49 0.94% 52.60 2524.00 25.51 4.47 1.98 7.44 17.76
Omega Healthcare Investors Inc
0.38 1.12% 34.42 31.33 10.13 9.06 2.05 14.35 15.26
Healthcare Realty Trust Incorporated
0.42 2.50% 17.39 - 10.83 4.82 0.93 8.92 15.95

Reports Covered

Stock Research & News


DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

Diversified Healthcare Trust

Two Newton Place, Newton, MA, United States, 02458-1634

Key Executives

Name Title Year Born
Mr. Adam David Portnoy Managing Chair of the Board 1970
Ms. Jennifer F. Francis Pres, CEO & Managing Trustee 1965
Mr. Richard W. Siedel Jr. CFO & Treasurer 1980
Mr. Michael B. Kodesch Director of Investor Relations NA
Mr. David M. Blackman Director of Acquisition NA
Ms. Jennifer Babbin Clark Sec. 1961
Mr. Matthew C. Brown CFO & Treasurer 1983
Mr. Christopher J. Bilotto President & CEO 1978
Ms. Jennifer Babbin Clark Secretary 1961
Melissa Mccarthy Manager of Investor Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.